Application Site Adverse Events of Topical Nonsteroidal Immunomodulators: A Post‐Marketing Analysis of the FDA Adverse Event Reporting System

Key Points

• The research aims to analyze adverse events associated with topical nonsteroidal immunomodulators reported to the FDA.
• Post-marketing analysis using data from the FDA Adverse Event Reporting System.
• Assessment of reported adverse events related to topical immunomodulators.
• Identification of various adverse events linked to topical nonsteroidal immunomodulators.
• Analysis reveals trends and frequencies of reported adverse events.